The clinical utility of next generation sequencing for IDHwt glioblastoma

Neuro-Oncology: The Podcast

English - February 11, 2022 17:00 - 22 minutes - 20.5 MB - ★★★★★ - 9 ratings
Medicine Health & Fitness Science Life Sciences brain oncology tumors glioblastoma glioma lymphoma neurology neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Trabectedin for recurrent grade 2 or 3 meningiomas

Next Episode: Clinical trial accrual for women and minorities in neuro-oncology

Dr. Evan Noch interviews Dr. Mary Jane Lim-Fat about her and her team's recent manuscript entitled: "Clinical utility of targeted next generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making", published online in Neuro-Oncology in December 2021.